These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37685704)

  • 21. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy?
    Moizard MP; Billard C; Toutain A; Berret F; Marmin N; Moraine C
    Am J Med Genet; 1998 Oct; 80(1):32-41. PubMed ID: 9800909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and characterization of dystrophin and Dp71, two products of the Duchenne Muscular Dystrophy gene, in zebrafish.
    Bolaños-Jiménez F; Bordais A; Behra M; Strähle U; Mornet D; Sahel J; Rendón A
    Gene; 2001 Aug; 274(1-2):217-26. PubMed ID: 11675014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies.
    Chamova T; Guergueltcheva V; Raycheva M; Todorov T; Genova J; Bichev S; Bojinova V; Mitev V; Tournev I; Todorova A
    Balkan J Med Genet; 2013 Jun; 16(1):21-30. PubMed ID: 24265581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third case of Duchenne muscular dystrophy and West syndrome: Expanding the spectrum of the DMD neuropsychiatric phenotype.
    Peña-Padilla C; Romero-Valenzuela I; Baldomero-López A; Sandoval-Talamantes AK; Castellanos-González A; Nagy PL; Kelly RR; Corona-Rivera JR
    Neuromuscul Disord; 2021 May; 31(5):462-465. PubMed ID: 33741226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls.
    Mendell JR; Khan N; Sha N; Eliopoulos H; McDonald CM; Goemans N; Mercuri E; Lowes LP; Alfano LN;
    J Neuromuscul Dis; 2021; 8(4):469-479. PubMed ID: 33523015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.
    Ricotti V; Jägle H; Theodorou M; Moore AT; Muntoni F; Thompson DA
    Eur J Hum Genet; 2016 Apr; 24(4):562-8. PubMed ID: 26081639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophy.
    Li X; Lv J; Zhu W; Hong S; Wang Z; Chang X; Gao YX; Zhou Y; Jia C; Fang J; Patterson TA
    Lancet Reg Health West Pac; 2024 Jan; 42():100944. PubMed ID: 38089167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
    Kreis R; Wingeier K; Vermathen P; Giger E; Joncourt F; Zwygart K; Kaufmann F; Boesch C; Steinlin M
    NMR Biomed; 2011 Apr; 24(3):253-62. PubMed ID: 21404337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.
    Matsuo M; Awano H; Matsumoto M; Nagai M; Kawaguchi T; Zhang Z; Nishio H
    Genes (Basel); 2017 Oct; 8(10):. PubMed ID: 28974057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.
    Preethish-Kumar V; Shah A; Kumar M; Ingalhalikar M; Polavarapu K; Afsar M; Rajeswaran J; Vengalil S; Nashi S; Thomas PT; Sadasivan A; Warrier M; Nalini A; Saini J
    AJNR Am J Neuroradiol; 2020 Jul; 41(7):1271-1278. PubMed ID: 32616576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up.
    Heydemann A; Bieganski G; Wachowiak J; Czarnota J; Niezgoda A; Siemionow K; Ziemiecka A; Sikorska MH; Bozyk K; Tullius SG; Siemionow M
    Stem Cell Rev Rep; 2023 Jul; 19(5):1340-1359. PubMed ID: 37000376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of the distal dystrophin isoforms Dp140 and Dp71 in the human epileptic hippocampus in relation to cognitive functioning.
    Hoogland G; Hendriksen RGF; Slegers RJ; Hendriks MPH; Schijns OEMG; Aalbers MW; Vles JSH
    Hippocampus; 2019 Feb; 29(2):102-110. PubMed ID: 30069964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy.
    Hashimoto Y; Kuniishi H; Sakai K; Fukushima Y; Du X; Yamashiro K; Hori K; Imamura M; Hoshino M; Yamada M; Araki T; Sakagami H; Takeda S; Itaka K; Ichinohe N; Muntoni F; Sekiguchi M; Aoki Y
    Prog Neurobiol; 2022 Sep; 216():102288. PubMed ID: 35654209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular localization of dystrophin isoforms in cardiomyocytes and phenotypic analysis of dystrophin-deficient mice reveal cardiac myopathy is predominantly caused by a deficiency in full-length dystrophin.
    Masubuchi N; Shidoh Y; Kondo S; Takatoh J; Hanaoka K
    Exp Anim; 2013; 62(3):211-7. PubMed ID: 23903056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy.
    Doorenweerd N; Mahfouz A; van Putten M; Kaliyaperumal R; T' Hoen PAC; Hendriksen JGM; Aartsma-Rus AM; Verschuuren JJGM; Niks EH; Reinders MJT; Kan HE; Lelieveldt BPF
    Sci Rep; 2017 Oct; 7(1):12575. PubMed ID: 28974727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration.
    Siemionow M; Biegański G; Niezgoda A; Wachowiak J; Czarnota J; Siemionow K; Ziemiecka A; Sikorska MH; Bożyk K; Heydemann A
    Stem Cell Rev Rep; 2023 Nov; 19(8):2724-2740. PubMed ID: 37707670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology.
    Wijekoon N; Gonawala L; Ratnayake P; Dissanayaka P; Gunarathne I; Amaratunga D; Liyanage R; Senanayaka S; Wijesekara S; Gunasekara HH; Vanarsa K; Castillo J; Hathout Y; Dalal A; Steinbusch HWM; Hoffman E; Mohan C; de Silva KRD
    Heliyon; 2023 Aug; 9(8):e18530. PubMed ID: 37593636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants.
    Pillers DA; Weleber RG; Green DG; Rash SM; Dally GY; Howard PL; Powers MR; Hood DC; Chapman VM; Ray PN; Woodward WR
    Mol Genet Metab; 1999 Feb; 66(2):100-10. PubMed ID: 10068512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.